Transplantation studies in mice and rats have shown that human embryonic-stem-cell-
derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts,,, but two …

Background—The cause of idiopathic dilated cardiomyopathy (DCM) is unknown by
definition, but its familial subtype is considered to have a genetic component. We …

Early career academic cardiologists currently face unprecedented challenges that threaten a
highly valued career path. A team consisting of early career professionals and senior …

Background: As heart failure prevalence continues to increase in the setting of a static donor
supply, left ventricular assist device (LVAD) therapy for end-stage heart failure continues to …

Background Patients with heart failure are at increased risk of both sudden death and pump
failure death. Strategies to better identify those who have greatest net benefit from …

Objectives: This study examined patient outcomes after left ventricular assist device (LVAD)
implantation across a range of center surgical volumes. Background: In order for a center to …

Opinion statement Right ventricular (RV) dysfunction in the setting of cardiomyopathy,
ischemia, and pulmonary hypertension is associated with high morbidity and mortality, but …

Objectives: The goal of this research was to identify disparities in risk within heart transplant
urgency designations. Background: Patients with left ventricular assist devices (LVADs) are …

Background: The number of adult congenital heart disease (CHD) patients undergoing heart
transplantation is increasing rapidly. CHD patients have higher surgical risk at …

Background Preoperative variables can predict short term left ventricular assist device
(LVAD) survival, but predictors of extended survival remain insufficiently characterized …